Cutaneous lymphocyte antigen (CLA) is a potential therapeutic target in cutaneous T cell lymphoma. (September 2022) - Poglio, S; Péru, S; Prochazkova-Carlotti, M; Cherrier, F; Velazquez, J; Richard, E; Idrissi, Y; Cappellen, D; Azzi-Martin, L; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP